Delivery Order SPE2DB22D3011-SPE2DB24FQ0EL

Award Date 3/28/24
Potential Completion Date 3/29/24
Potential Value $2.2K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is a delivery order with a firm fixed price for the supply of Methylphenidate ER 36 mg tablets. The award has a ceiling value of $2,023.06 and a performance period through April 15, 2024. Amerisourcebergen Drug Corp holds an...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract, valued at up to $1,037.49, is a firm fixed price delivery order for 4,564,246,701 units of the prescription drug Methylphenidate ER 18 mg tablets. The contract has an ultimate completion date of April 12, 2024 and does not have a set-aside designation....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of 4,564,327,427 units of Methylphenidate ER 36 mg tablets. The $1,505.38 Firm Fixed Price Delivery Order has an ultimate completion date of April 19, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth up to $999,999,999.00 through December 31,...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $2,090.68 firm fixed price delivery order is for the supply of Methylphenidate ER 54 mg tablets. The contract has a performance period through March 27, 2024 and does not have a set-aside designation. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to $999,999,999.00...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 27 mg tablets of the pharmaceutical product Methylphenidate ER. The $1,566.00 contract has a completion date of March 5, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, as well as an indefinite delivery contract (IDC) with DLA valued up to $999,999,999.00 through December 2025. This...
The Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Methylphenidate ER 36 mg tablets. The contract has a potential value of $4,506.64 and a completion date of February 13, 2024. Amerisourcebergen Drug Corp, as a prime contractor, is responsible for providing this pharmaceutical product to support military treatment programs and facilities. The...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order valued at $1,787.40 to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The award is for the provision of 4,563,637,880 milligrams of the drug Methylphenidate ER 18 mg tablets, with a completion date of February 13, 2024. This order is placed under Amerisourcebergen Drug Corp's single award indefinite delivery...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of Methylphenidate ER 54 mg tablets. The $1,940.17 contract has a completion date of February 21, 2024. AmerisourceBergen Drug Corp, a for-profit organization, serves as the prime contractor on this delivery order as well as on an indefinite delivery contract (IDC) with DLA Troop Support...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) to provide Methylphenidate ER 18 mg tablets. The Firm Fixed Price Delivery Order, valued at $1,819.33, has an ultimate completion date of November 25, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $4,589.30 firm fixed-price delivery order is for the supply of 4565828390 - Methylphenidate ER 36 mg tablets in 100-count bottles. The contract has an ultimate completion date of September 17, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to...
  • SPE2DB22D3011
    Indefinite Delivery Contract
  • SPE2DB22D3011-SPE2DB24FQ0EL
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply Methylphenidate ER 36 mg tablets. The $2,167.09 firm fixed price delivery order has an ultimate completion date of March 29, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to provide pharmaceutical products and medical supplies to support the Department of Defense's military treatment programs and facilities worldwide. This contract award does not have a set-aside designation.

Generated 6/27/24, 10:59 AM